After signing DiaDexus as its second pharmaceutical partner last month, Beyond Genomics last week chose Micromass to provide liquid chromatography and mass spectrometry equipment for the systems biology company’s proteomics platform.
After signing DiaDexus as its second pharmaceutical partner last month, Beyond Genomics last week chose Micromass to provide liquid chromatography and mass spectrometry equipment for the systems biology company’s proteomics platform.
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
You may already have institutional access!
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.